IP Library Patent Application 13837777
Patent Application
App. No. 13/837,777

GRADUAL TRANSITION BETWEEN BASAL RATES IN AN AMBULATORY DRUG DELIVERY DEVICE

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
13/837,777
Abstract

A controller in an ambulatory drug delivery device automatically creates gradual transitions between basal rates entered by a user. The user may enter at least two target basal rates and two corresponding durations for delivering a medication at each rate. Systems and methods for such drug delivery are described.

Claims (33)

1 . A system for administering medication to a patient, comprising:

an infusion pump; and

software associated with the infusion pump configured to automatically provide a basal medication dosage profile that is based upon input from a user, the basal medication dosage profile comprising

at least two target basal rates;

a first duration for administering a medication to the patient at a first target basal rate; and

a second duration for administering the medication at a second target basal rate; and

at least one transition period over which a delivered basal rate gradually transitions between the target basal rates.

2 . The system of claim 1 , wherein the transition period is automatically set by the software.

3 . The system of claim 1 , wherein the transition period is set by the user.

4 . The system of claim 1 , wherein the infusion pump is configured to administer the medication such that a first volume administered in a first dose is either the same as or is different from a second volume administered in a second dose.

5 . The system of claim 1 , wherein a slope of a plot of the basal medication dosage profile as basal rate versus time provided by the software is non-zero and not infinity over the at least one transition period.

6 . The system of claim 1 , wherein the at least one transition period occurs over a fixed time period.

7 . The system of claim 1 , wherein the basal medication dosage profile includes at least two transition periods and each transition period has a duration that is constant within the basal medication dosage profile.

8 . The system of claim 7 , wherein the infusion pump is configured to administer medication doses at fixed time intervals.

9 . The system of claim 8 , wherein the duration of each transition period is an amount of time (T) that yields a whole number when divided by a duration (t) of the fixed dosage time intervals.

10 . The system of claim 9 , wherein the duration (t) of the fixed dosage time intervals is 5 minutes.

11 . The system of claim 10 , wherein the duration of each transition period (T) is 15 minutes, 30 minutes, 60 minutes, 90 minutes, or 120 minutes.

12 . The system of claim 10 , wherein the duration of each transition period (T) is 60 minutes.

13 . The system of claim 1 , wherein the user provides input using a user interface located on the infusion pump or on a remote device.

14 . A method of delivering a medicament to a patient, comprising:

accepting, from a user via software associated with an infusion pump, at least two rates of medicament delivery and periods of time during a 24 hour period corresponding to each rate of medicament delivery;

generating a rate profile based upon the at least two rates of medicament delivery and periods of time using the software associated with the infusion pump; and

providing the rate profile to a controller associated with the infusion pump to direct administration of the medicament to the patient,

wherein the rate profile comprises a transition period between the at least two rates of medicament delivery over which a delivered rate gradually transitions between the two rates.

15 . The method of claim 14 , wherein the transition period has a duration chosen by the user.

16 . The method of claim 14 , wherein the transition period has a duration automatically determined by the software.

17 . The method of claim 14 , wherein the infusion pump is configured to administer medicament doses at fixed time intervals.

18 . The method of claim 17 , wherein the duration of each transition period is an amount of time (T) that yields a whole number when divided by a duration (t) of the fixed dosage time intervals.

19 . The system of claim 18 , wherein the duration (t) of the fixed dosage time intervals is 5 minutes.

20 . The system of claim 14 , wherein the pump administers the medication in a different volume for each dose administered during transition periods.

21 . The method of claim 14 , further comprising further refining the basal rate profile.

22 . The method of claim 21 , wherein further refining the basal rate profile comprises the user providing additional information.

23 . The method of claim 22 , wherein the additional information comprises more basal rate intervals, new values for existing basal rate intervals, or both.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Aug 10, 2018
From: CAPITAL ROYALTY PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II L.P. - PARALLEL FUND "A" L.P.; PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II (CAYMAN) L.P.
To: TANDEM DIABETES CARE, INC.
Reel/Frame 046761/0843 →
SHORT-FORM PATENT SECURITY AGREEMENT Recorded Apr 4, 2014
From: TANDEM DIABETES CARE, INC.
To: CAPITAL ROYALTY PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.P.; PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II (CAYMAN) L.P.
Reel/Frame 032608/0780 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 27, 2013
From: SAINT, SEAN
To: TANDEM DIABETES CARE, INC.
Reel/Frame 030699/0626 →